157 related articles for article (PubMed ID: 7576977)
1. First line targeted radiotherapy, a new concept in the treatment of advanced stage neuroblastoma.
De Kraker J; Hoefnagel CA; Caron H; Valdés Olmos RA; Zsiros J; Heij HA; Voûte PA
Eur J Cancer; 1995; 31A(4):600-2. PubMed ID: 7576977
[TBL] [Abstract][Full Text] [Related]
2. [131I]MIBG as a first line treatment in advanced neuroblastoma.
Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):61-4. PubMed ID: 9002752
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment with [131I] metaiodobenzylguanidine and surgical resection of advanced neuroblastoma.
van Hasselt EJ; Heij HA; de Kraker J; Vos A; Voûte PA
Eur J Pediatr Surg; 1996 Jun; 6(3):155-8. PubMed ID: 8817208
[TBL] [Abstract][Full Text] [Related]
4. Treatment with meta-[131I]iodobenzylguanidine and cisplatin in stage IV neuroblastoma.
Mastrangelo S; Tornesello A; Diociaiuti L; Riccardi R; Rufini V; Troncone L
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):69-71. PubMed ID: 9002754
[TBL] [Abstract][Full Text] [Related]
5. The treatment of neuroblastoma with [131I]MIBG at diagnosis.
Troncone L; Rufini V; Luzi S; Mastrangelo R; Riccardi R
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):65-8. PubMed ID: 9002753
[TBL] [Abstract][Full Text] [Related]
6. [131I]-metaiodobenzylguanidine in the treatment of metastatic neuroblastoma. Clinical, pharmacological and dosimetric aspects.
Klingebiel T; Treuner J; Ehninger G; Keller KD; Dopfer R; Feine U; Niethammer D
Cancer Chemother Pharmacol; 1989; 25(2):143-8. PubMed ID: 2598401
[TBL] [Abstract][Full Text] [Related]
7. Treatment of neuroblastoma with [125I]metaiodobenzylguanidine.
Sisson JC; Shapiro B; Hutchinson RJ; Zasadny KR; Mallette S; Mudgett EE; Wieland DM
J Nucl Biol Med (1991); 1991; 35(4):255-9. PubMed ID: 1823830
[TBL] [Abstract][Full Text] [Related]
8. A new approach in the treatment of stage IV neuroblastoma using a combination of [131I]meta-iodobenzylguanidine (MIBG) and cisplatin.
Mastrangelo R; Tornesello A; Riccardi R; Lasorella A; Mastrangelo S; Mancini A; Rufini V; Troncone L
Eur J Cancer; 1995; 31A(4):606-11. PubMed ID: 7576979
[TBL] [Abstract][Full Text] [Related]
9. 131I-MIBG as a first-line treatment in high-risk neuroblastoma patients.
Hoefnagel CA; De Kraker J; Valdés Olmos RA; Voûte PA
Nucl Med Commun; 1994 Sep; 15(9):712-7. PubMed ID: 7816384
[TBL] [Abstract][Full Text] [Related]
10. Preoperative [131I]metaiodobenzylguanidine therapy of neuroblastoma at diagnosis ("MIBG de novo").
Hoefnagel CA; de Kraker J; Voûte PA; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):248-51. PubMed ID: 1823828
[TBL] [Abstract][Full Text] [Related]
11. Toxicity from treatment of neuroblastoma with 131I-meta-iodobenzylguanidine.
Sisson JC; Hutchinson RJ; Carey JE; Shapiro B; Johnson JW; Mallette SA; Wieland DM
Eur J Nucl Med; 1988; 14(7-8):337-40. PubMed ID: 3181182
[TBL] [Abstract][Full Text] [Related]
12. [131I]metaiodobenzylguanidine therapy in advanced neuroblastoma.
Claudiani F; Garaventa A; Bertolazzi L; Villavecchia GP; Cabria M; Scopinaro G; Bestagno M; Guerra P; Canevarollo N; Scielzo G
J Nucl Biol Med (1991); 1991; 35(4):224-7. PubMed ID: 1823823
[TBL] [Abstract][Full Text] [Related]
13. Iodine-125-MIBG to treat neuroblastoma: preliminary report.
Sisson JC; Hutchinson RJ; Shapiro B; Zasadny KR; Normolle D; Wieland DM; Wahl RL; Singer DA; Mallette SA; Mudgett EE
J Nucl Med; 1990 Sep; 31(9):1479-85. PubMed ID: 2395016
[TBL] [Abstract][Full Text] [Related]
14. Place of meta-[131I]iodobenzylguanidine in the treatment of neuroblastoma: the Genoa experience.
Garaventa A; Pianca C; Conte M; Nigro M; De Bernardi B; Claudiani F; Stimamiglio P; Bertolazzi L; Cabria M; Villavecchia GP
Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):58-60. PubMed ID: 9002751
[TBL] [Abstract][Full Text] [Related]
15. 131-I-metaiodobenzylguanidine treatment in patients with refractory advanced neuroblastoma.
Hutchinson RJ; Sisson JC; Shapiro B; Miser JS; Normole D; Shulkin BL; Francis IR; Zasadny K; Carey JE; Johnson JW
Am J Clin Oncol; 1992 Jun; 15(3):226-32. PubMed ID: 1590275
[TBL] [Abstract][Full Text] [Related]
16. New MIBG preparation to improve targeted radiotherapy and reduce toxic side-effects in neuroblastoma patients undergoing combination treatment.
Mairs RJ; Zalutsky MR
Br J Cancer; 1995 Jul; 72(1):250. PubMed ID: 7599061
[No Abstract] [Full Text] [Related]
17. Predictors of toxicity in treating patients with neuroblastoma by radiolabeled metaiodobenzylguanidine.
Sisson JC; Shapiro B; Hutchinson RJ; Carey JE; Zasadny KR; Zempel SA; Normolle DP
Eur J Nucl Med; 1994 Jan; 21(1):46-52. PubMed ID: 8088285
[TBL] [Abstract][Full Text] [Related]
18. Treatment of advanced neuroblastoma with I-131 meta-iodobenzylguanidine.
Garaventa A; Guerra P; Arrighini A; Bertolazzi L; Bestagno M; De Bernardi B; Lanino E; Villavecchia GP; Claudiani F
Cancer; 1991 Feb; 67(4):922-8. PubMed ID: 1991264
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of [131I]metaiodobenzylguanidine therapy for patients with refractory neuroblastoma.
Matthay KK; Huberty JP; Hattner RS; Ablin AR; Engelstad BL; Zoger S; Hasegawa BH; Price D
J Nucl Biol Med (1991); 1991; 35(4):244-7. PubMed ID: 1823827
[TBL] [Abstract][Full Text] [Related]
20. [131I]metaiodobenzylguanidine therapy after conventional therapy for neuroblastoma.
Hoefnagel CA; Voûte PA; De Kraker J; Valdés Olmos RA
J Nucl Biol Med (1991); 1991; 35(4):202-6. PubMed ID: 1823819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]